Variable ganciclovir concentrations in a critically ill patient receiving continuous renal replacement therapy and plasma exchange?
Burns, Trauma and Critical Care Research Centre, The University of Queensland, Herston, QLD, Australia; UGC Farmacia/UGC Intercentros Enfermedades Infecciosas, Microbiologia y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocio, Seville, Spain.
Maria
M
Nunez-Nunez
Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Judith
J
Bellapart
Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Steven
S
O'Donoghue
Pathology Queensland, Herston, QLD, Australia.
Brett
B
McWhinney
Pathology Queensland, Herston, QLD, Australia.
Jacobus P J
JP
Ungerer
Burns, Trauma and Critical Care Research Centre, The University of Queensland, Herston, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Jeffrey
J
Lipman
Burns, Trauma and Critical Care Research Centre, The University of Queensland, Herston, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia. Electronic address: j.roberts2@uq.edu.au.
Jason A
JA
Roberts
D000328:Adult; D000998:Antiviral Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016638:Critical Illness; D005260:Female; D015774:Ganciclovir / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D010949:Plasma / Q000737:chemistry*; D010951:Plasma Exchange; D017582:Renal Replacement Therapy
D000998:Antiviral Agents; D015774:Ganciclovir
CVVHDF; Drug removal; Pharmacokinetics; Plasmapheresis; Therapeutic plasma exchange